# Fibrinogen Concentrate (Human) - Efficacy and Safety Study

> **NCT00916656** · PHASE3 · WITHDRAWN · sponsor: **CSL Behring**

## Conditions studied

- Afibrinogenemia
- Hypofibrinogenemia
- Fibrinogen Deficiency

## Interventions

- **BIOLOGICAL:** Fibrinogen Concentrate, Human (FCH)
- **BIOLOGICAL:** Cryoprecipitate

## Key facts

- **NCT ID:** NCT00916656
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916656, "Fibrinogen Concentrate (Human) - Efficacy and Safety Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00916656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*